1. HOME
  2. About Us
  3. Company Profile
  4. Consolidated Company Outline

Consolidated Company Outline

Company Name Olympus Corporation
Market Tokyo Stock Exchange, Prime Market
Stock Code ISIN: JP3201200007
Established October 12, 1919
Head Office 2951 Ishikawa-machi, Hachioji-shi, Tokyo 192-8507, Japan

Map
Share Capital 124.643 billion yen (As of March 31, 2025)
Consolidated Revenue 997.3 billion yen (Fiscal year ended March 31, 2025)
Consolidated Headcount 29,297 (As of March 31, 2025)

Revenue by Business Divisions

Fiscal year ended March 2025: Consolidated revenue 997.3 billion Yen. Share of revenue by business segment: Endoscopic Solutions 636.1 billion Yen 63.8%, Therapeutic Solutions 360.7 billion Yen 36.2%, and Other 0.5 billion Yen 0.1%.

* Due to rounding, the total may not add up to 100%

Revenue by Region

Fiscal year ended March 2025: Consolidated revenue 997.3 billion Yen. Japan 110.1 billion Yen 11%, North America 413.8 billion Yen 42%, Europe 254.6 billion Yen 26%, China 95.7 billion Yen 10%, Asia and Oceania 93.7 billion Yen 9%, Other Region 28.8 billion Yen 3%.

* Due to rounding, the total may not add up to 100%

Number of Group Companies

84 (Excluding Olympus Corporation)

Revenue and Operating Profit

Revenue and operating profit, fiscal year ended March: 2021 Revenue 730.5 billion Yen, operating profit 82.0 billion Yen. 2022 Revenue 868.9 billion Yen, operating profit 153.9 billion Yen. 2023 Revenue 881.9 billion Yen, operating profit 186.6 billion Yen. 2024 Revenue 925.8 billion Yen, operating profit 51.4 billion Yen. 2025 Revenue 997.3 billion Yen, operating profit 162.5 billion Yen.

* Due to rounding, the total may not add up to 100%

Endoscopic Solutions ¥360.7B:GI Endoscopy55%* Surgical Endoscopy10%* Medical Service35%*, Therapeutic Solutions ¥360.7B: GI EndoTherapy30%* Urology35%* Respiratory15%* Other Therapeutic Areas20%*

* Due to rounding, the total may not add up to 100%